We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Apotex Fails to Win Hearing in Supreme Court on Plavix
Apotex Fails to Win Hearing in Supreme Court on Plavix
November 10, 2009
The Supreme Court denial of Apotex’s petition challenging a patent on Sanofi-Aventis and Bristol-Myers Squibb’s (BMS) blood-thinner drug Plavix protects a patent on the drug that Apotex had contended was not strong enough to maintain exclusivity.